Cargando…

Optimal Systemic Treatment of Advanced Bladder Cancer—A Moving Target

Detalles Bibliográficos
Autores principales:	Pappot, Helle, Ullén, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761602/ https://www.ncbi.nlm.nih.gov/pubmed/33276590 http://dx.doi.org/10.3390/cancers12123607

Ejemplares similares

Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach
por: Pappot, Helle, et al.
Publicado: (2023)

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis
por: Holmsten, Karin, et al.
Publicado: (2016)

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis
por: Holmsten, Karin, et al.
Publicado: (2017)

Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
por: Taarnhøj, Gry A., et al.
Publicado: (2020)

Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
por: Taarnhøj, Gry Assam, et al.
Publicado: (2019)

Biomarkers for immunotherapy in bladder cancer: a moving target
por: Aggen, David H., et al.
Publicado: (2017)

Phenotyping pulmonary hypertension in systemic sclerosis: a moving target
por: Mercurio, Valentina, et al.
Publicado: (2018)

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
por: Culine, Stéphane, et al.
Publicado: (2018)

Advances in Management of Bladder Cancer
por: Racioppi, Marco
Publicado: (2021)

Optimized management in patients with bladder cancer
por: Babjuk, Marek
Publicado: (2015)

Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
por: Packiam, Vignesh T.
Publicado: (2020)

The moving target of psychiatric diagnosis
por: Alda, Martin
Publicado: (2021)

Safety in healthcare is a moving target
por: Vincent, Charles, et al.
Publicado: (2015)

Safety and Activity of Sorafenib in Addition to Vinflunine in Post‐Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial
por: Shah, Carl‐Henrik, et al.
Publicado: (2018)

Sepsis and the theory of relativity: measuring a moving target with a moving measuring stick
por: Klompas, Michael, et al.
Publicado: (2016)

Moving Toward the Optimal Test for the Assessment of Myocardial Ischemia
por: Nagel, Eike
Publicado: (2016)

The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial
por: Taarnhøj, Gry Assam, et al.
Publicado: (2023)

Metastatic cells: moving onco-targets
por: Patsialou, Antonia, et al.
Publicado: (2014)

Optimal search for moving targets
por: Stone, Lawrence D, et al.
Publicado: (2016)

Cancer Treatment in CKD: Time to Move Beyond Renalism
por: Berger, Joseph Rossi, et al.
Publicado: (2023)

Advanced practice in radiotherapy: How to move to the next level?
por: Tsang, Yat, et al.
Publicado: (2021)

Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature
por: Taarnhøj, G. A., et al.
Publicado: (2019)

The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review
por: Beauchamp, Ulrikke Lyng, et al.
Publicado: (2020)

Correction to: Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature
por: Taarnhøj, G. A., et al.
Publicado: (2020)

Prognosis for Mechanically Ventilated Patients: A Moving Target
por: Zaeh, Sandra E., et al.
Publicado: (2020)

Advancing together and moving forward: Combination gene and cellular immunotherapies
por: Priceman, Saul J., et al.
Publicado: (2022)

GSE moves to a new system of submission
Publicado: (2005)

Advances in nonmuscle invasive bladder cancer
por: Konety, Badrinath R.
Publicado: (2015)

Muscle mass and physical function in patients with bladder cancer—Data from a prematurely terminated prospective cohort study
por: Omland, Lise Høj, et al.
Publicado: (2022)

Moving
Publicado: (1917)

Moving on
por: McMullan, Roz
Publicado: (2022)

Palliative Care for Patients With Advanced CKD: Moving Beyond the Status Quo
por: Lu, Emily, et al.
Publicado: (2019)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Treatment of Chronic Kidney Disease: Moving Forward
por: Garibotto, Giacomo, et al.
Publicado: (2022)

Thulium laser treatment for bladder cancer
por: Wang, Wei, et al.
Publicado: (2016)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Advances in Systemic Lupus Erythematosus (SLE): A case for optimism
por: Fanouriakis, Antonis, et al.
Publicado: (2017)

Moving forward
por: Li, Li
Publicado: (2020)

Moving ahead
por: Jagannathan, Mukund
Publicado: (2015)

Psychotraumatology on the move
por: Olff, Miranda
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n6425vh6ntjt2a9f62h89r2egn